Detalhe da pesquisa
1.
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials.
Aesthet Surg J
; 38(9): 998-1010, 2018 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29401213
2.
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction.
Dermatol Surg
; 42(1): 38-49, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26673433
3.
Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat.
Dermatol Surg
; 42 Suppl 1: S263-S270, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27787266
4.
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat.
Dermatol Surg
; 42 Suppl 1: S288-S299, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27787269
5.
An interrater and intrarater reliability study of 3 photographic scales for the classification of perioral aesthetic features.
Dermatol Surg
; 40(6): 663-70, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24852471
6.
Juvederm ultra for lip enhancement: an open-label, multicenter study.
Aesthet Surg J
; 33(3): 414-20, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23515385
7.
Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds.
Plast Reconstr Surg
; 121(1): 289-297, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18176233